Background & aims To assess the prevalence of sarcopenia before cancer treatment and its
predictive value during the treatment. Methods We searched MEDLINE via PubMed for …

Body composition, defined as the proportions and distribution of lean and fat tissues in the
human body, is an emergent theme in clinical oncology. Severe muscle depletion …

Objective: The aim of the study was to evaluate sarcopenia as a predictor of postoperative
risk of major and total complications after surgery for gastrointestinal cancer. Background …

Background The optimal nutritional therapy in the field of pancreatic surgery is still debated.
Methods An international panel of recognized pancreatic surgeons and pancreatologists …

Assessment of a low skeletal muscle mass (SM) is important for diagnosis of ageing and
disease-associated sarcopenia and is hindered by heterogeneous methods and …

Backround The role of sarcopenia and sarcopenic obesity in patients with pancreatic ductal
adenocarcinoma (PDAC) remains controversial. Material and Methods Medline and Web of …

Unintentional weight loss in patients with pancreatic cancer is highly prevalent and
contributes to low therapeutic tolerance, reduced quality of life, and overall mortality. Weight …

Clinicians often believe that cachexia is caused by cancer and anorexia as a toxicity of
chemotherapy or targeted anti-cancer agents. It is now recognized that chemotherapy and …

Background Previous cohort studies investigating the association between sarcopenic
obesity (SO) and all-cause mortality among adult people have been inconsistent. We …

In recent years, both the actual number of overweight/obese individuals and their proportion
of the population have steadily been rising worldwide and obesity‐related diseases have …